![Ying Luo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ying Luo
Fondateur chez
GNI GROUP LTD.
Fortune : 41 M $ au 31/05/2026
Profil
Ying Luo is the founder of Shanghai Genomics, Inc., founded in 2001, serving as Chairman.
Dr. Luo is the founder of GNI Group Ltd., founded in 2005, serving as Executive President, CEO & Representative Director.
Dr. Luo was the founder of Cullgen, Inc., founded in 2018, serving as Chairman, President & Chief Executive Officer.
Current jobs included Chairman & Chief Executive Officer at GNI-EPS Pharmaceuticals, inc.
since 2010; President, Chief Executive Officer & Director at Gyre Therapeutics, Inc. starting 2026; Chairman, President & Chief Executive Officer at Cullgen, Inc. (New); Chairman at Continent Pharmaceutical, Inc. since 2011; Chairman & General Manager at Cullgen Shanghai, Inc. since 2018; Chairman at Shanghai GEP Pharmaceuticals, Inc. since 2017; President & Director at GNI Hong Kong Ltd. since 2013; and President & Director at GNI USA, Inc. since 2015.
Former jobs include Chairman at Catalyst Biosciences, Inc.; Chairman at Beijing Continent Pharmaceutical Co., Ltd. from 2011 to 2025; Chairman at Gyre Therapeutics, Inc. from 2023 to 2025; Director at Berkeley Advanced Biomaterials, Inc.; Director-Functional Genomics Division II at Chinese National Genome Center from 2001 to 2011; and Adjunct Professor at Shanghai Jiao Tong University.
Education includes a doctorate from the University of Connecticut Health Center conferred in 1991 and an undergraduate degree from Peking Union Medical College conferred in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GNI GROUP LTD. 2,88% | 31/12/2025 | 1 607 700 ( 2,88% ) | 26 M $ | 31/05/2026 |
2,66% | 04/05/2026 | 2 575 541 ( 2,66% ) | 15 M $ | 31/05/2026 |
Postes actifs de Ying Luo
| Sociétés | Poste | Début |
|---|---|---|
| GNI GROUP LTD. | Fondateur | 01/06/2005 |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Président | 01/09/2011 |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | 01/11/2017 |
Cullgen Shanghai, Inc. | Président | 01/06/2018 |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Fondateur | 01/05/2001 |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | President | 01/01/2015 |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | President | - |
GNI-EPS Pharmaceuticals, inc. | Directeur Général | 01/11/2010 |
Anciens postes connus de Ying Luo
| Sociétés | Poste | Fin |
|---|---|---|
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Directeur Général | 04/05/2026 |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Ying Luo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products | Health Technology |
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GNI Group Ltd.
 GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products | Health Technology |
Chinese National Genome Center | |
Peking Union Medical College
 Peking Union Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Health Technology |
GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | Commercial Services |
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells biological technology medicines | Health Technology |
Cullgen Shanghai, Inc. | |
Shanghai GEP Pharmaceuticals, Inc.
Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
